Lakewood-Amedex Biotherapeutics Inc. Share Price
NASDAQ: LABTLakewood-Amedex Biotherapeutics Inc. Stock Performance
Lakewood-Amedex Biotherapeutics Inc. Share Price Today
As of 14 November 2026, Lakewood-Amedex Biotherapeutics Inc.'s share price is $0.28. The stock opened at $0.33, compared to its previous close of $0.36. During today's trading session, Lakewood-Amedex Biotherapeutics Inc.'s share price traded between $0.25 and $0.33, with an average price of $0.29. Over the past 52 weeks, the stock has recorded a high of $9.06 and a low of $0.17. In terms of performance, Lakewood-Amedex Biotherapeutics Inc.'s share price has declined by 58.71% over the last six months and is down 89.37% on a year-on-year basis.
Lakewood-Amedex Biotherapeutics Inc. Share Price Chart
Lakewood-Amedex Biotherapeutics Inc. Quarterly Profit & Loss
All figures in USD
About Lakewood-Amedex Biotherapeutics Inc.
Lakewood-Amedex Biotherapeutics Inc is a clinical-stage biotechnology company developing a novel class of fast-acting, broad-spectrum antimicrobials - the Bisphosphocin class - to treat infectious diseases and reduce the threat posed by antibiotic-resistant bacterial strains, including MRSA, VRE, and others. The company's main product is Nu-3, a topically delivered antimicrobial gel in Phase 2 clinical trials for the treatment of mildly infected diabetic foot ulcers (iDFU). It is also advancing a portfolio of early-stage pipeline compounds developed from its Bisphosphocin platform targeting potential disease indications, including complicated urinary tract infection (cUTI) and pulmonary infections.
Lakewood-Amedex Biotherapeutics Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $0.18 | $0.28 | +37.81% |
Oct 2026 | $0.94 | $0.20 | -79.00% |
Sep 2026 | $2.68 | $0.96 | -61.57% |
Aug 2026 | $1.96 | $2.49 | +25.13% |
Jul 2026 | $3.14 | $1.99 | -42.82% |
Jun 2026 | $0.63 | $3.48 | +417.09% |
May 2026 | $4.21 | $0.67 | -74.26% |
Apr 2026 | $7.00 | $2.62 | N/A |